Back to Top Skip to main content

Editorial: Mitigating the Risk of Disease From Tick-borne Encephalitis in U.S. Military Populations

Female Ixodes ricinus Tick ©ECDC/Photo by Francis Schaffner Female Ixodes ricinus Tick ©ECDC/Photo by Francis Schaffner

Recommended Content:

Medical Surveillance Monthly Report

Tick-borne encephalitis (TBE) has been a recognized threat to public health and force health protection (FHP) among U.S. military service members and other beneficiaries since at least the 1970s. TBE is caused by TBE virus, which is transmitted to humans within minutes of attachment by infected Ixodes ricinus ticks.1 Chiefly endemic in wooded areas in central and eastern Europe and the Baltic and Nordic countries, transmission occurs mainly in the spring through early autumn.2 There is no treatment beyond supportive care, and the vast majority of those infected fully recover. However, despite intensive care intervention, the case fatality rate ranges from 0.5 to 20% depending on the subtype of TBE virus.3–5 In addition, incomplete recovery with long-term neurologic sequelae can occur in 26–46% of those symptomatic cases in Europe.4 Primary prevention for tick bites includes the use of protective clothing, such as long pants/sleeves, and the use of insect repellent,6 such as DEET (chemical name: N,N-diethyl-meta-toluamide; 20 to 50% concentration) and picaridin (at least 20% concentration), on the skin. Added protection is provided by treating clothing, tents, and other gear (but not skin) with the repellent permethrin. Several TBE vaccines are available for use in Europe but have not been widely used by U.S. military personnel residing in or deployed to endemic areas because of lack of licensure by the U.S. Food and Drug Administration (FDA).

The U.S. military has been involved in studying the impact of TBE among service members since the 1980s.7,8 In 1983, Immuno AG submitted an investigational new drug (IND) application to the FDA for the TBE vaccine FSME-Immun Inject® following 25 years of use in Europe.9,10 In February 1996, TBE guidance for the U.S. Commander in Chief, Europe, regarding personnel supporting Operation Joint Endeavor stressed adherence to personal protective measures and, if at high risk, consideration for voluntary receipt of an accelerated, 3-dose TBE vaccine series under an IND protocol.11 Findings from that protocol revealed a 20%, 60%, and 80% seroconversion in the 954 individuals who had received 1, 2, or 3 doses of TBE vaccine, respectively.12 Of the 959 unvaccinated individuals, 4 (0.42%) demonstrated seroconversion and all were asymptomatic.

In subsequent years, additional publications from Europe demonstrated the scope of TBE and the efficacy of TBE vaccine.13–17 In 2011, the World Health Organization published its first position paper on TBE vaccines, and in 2012, TBE became a reportable disease entity among countries in the European Union.13,18,19 Collectively, these reports, along with a few recent high-profile cases among U.S. military service members and beneficiaries stationed in Europe, piqued Department of Defense (DoD) interest for an updated review of both the magnitude of TBE disease and an approach toward management within the U.S. military population. However, it was quickly recognized that there are challenges in assessing TBE epidemiology in U.S. military populations, including lack of recognition of the disease among U.S. and host nation providers, incomplete reporting of recognized disease, and misclassification of vaccine administration as true disease in administrative medical records (Armed Forces Health Surveillance Branch, email communications, 23–24 September 2019). These issues resulted in a large amount of concern and uncertainty regarding the threat of TBE to U.S. personnel among not only medical and public health assets within the U.S. European Command (USEUCOM) but also among the supported operational forces.

The 2 articles on TBE in this issue of the MSMR constitute an effort to provide a more accurate and precise risk assessment for U.S. military personnel stationed or deployed in USEUCOM through high-quality data that are actionable and inform FHP posture. The first article presents surveillance data including trends in TBE disease from 2006 to 2018 in U.S. military populations in Europe and reports on the efforts to identify and validate cases through multiple data sources and records review. The second article describes an in-depth review of a series of TBE cases that occurred in 2017 and 2018 in the area supported by the U.S. Army Medical Department Activity-Bavaria. These articles highlight the value and power of the centralized Defense Medical Surveillance System (DMSS) in combination with in-depth review of medical records by medical and public health personnel. Together, the 2 articles provide objective evidence that the risk to U.S. service members and beneficiaries of contracting TBE disease in Europe is small but non-zero as well as some limited evidence of increasing risk in recent years.

The risk assessment presented in the first article is relevant to discussions of pursuing additional vaccine options to enhance FHP posture against TBE. DoD Instruction 6205.0220 establishes policy, assigns responsibilities, and provides procedures to establish a uniform DoD immunization program in accordance with the authority in DoD Directive 6200.0421 and DoD Instruction 1010.10.22 For infectious diseases identified within the U.S. or in areas with frequent U.S. travelers, the military (similar to the civilian population) relies on primary prevention tools, including FDA-approved immunizations, which are administered in accordance with recommendations from the Centers for Disease Control and Prevention (CDC) and its Advisory Committee on Immunization Practices (ACIP). However, given the worldwide assignments of DoD beneficiaries, there may be diseases, such as TBE, for which a host nation approved medical product may exist but for which the manufacturer has not submitted an application for U.S. FDA approval.

When there is no available FDA-approved medical product, under DoD Instruction 6200.02,23 a DoD component may request that the Assistant Secretary of Defense for Health Affairs (ASD-HA) authorize the voluntary use of an investigational medical product for FHP use. Such requests, approval, and implementation must comply with applicable laws and FDA regulations and would involve the provision of the non-FDA approved vaccine for FHP purposes on a voluntary basis under an Emergency Use Authorization or IND protocol. TBE vaccine is currently not an FHP requirement, but the host nation approved product is authorized for voluntary receipt through TRICARE for at-risk DoD beneficiaries in endemic areas of Europe and Asia when vaccine is received from TRICARE authorized providers.24

Both USEUCOM and the Defense Health Agency, through the Immunization Healthcare Branch, the Office of the ASDHA, and other key DoD stakeholders, are working together to reduce the barriers to vaccination and increase the availability of vaccines to U.S. military beneficiaries stationed in Europe. The challenges surrounding pursuing additional vaccination options and the considerations regarding associated resources to invest will continue to be guided by accurate, precise estimates of the disease burden like the ones provided in this issue of the MSMR. Additional seroepidemiologic studies are needed in areas where DoD beneficiaries reside to better define the distribution of TBE and to guide future TBE vaccination policies in areas with high TBE incidence.25 Furthermore, it cannot be overstated that protective measures against tick-borne diseases, such as TBE, remain grounded in primary prevention.


Author affiliations: Immunization Healthcare Branch, Public Health Division, Defense Health Agency, Falls Church, VA.

REFERENCES

1. Lindquist L, Vapalahti O. Tick-borne encephalitis. Lancet. 2008;371(9627):1861–1871. 

2. Beauté J, Spiteri G, Warns-Petit E, Zeller H. Tick-borne encephalitis in Europe, 2012 to 2016. Euro Surveill. 2018;23(45).

3. Kaiser R. The clinical and epidemiological profile of tick-borne encephalitis in southern Germany 1994–98: a prospective study of 656 patients. Brain. 1999;122:2067–2078.

4. Taba P, Schmutzhard E, Forsberg P, et al. EAN consensus review on prevention, diagnosis and management of tick-borne encephalitis. Eur J Neurol. 2017;24(10):1214–e1261.

5. LaSala PR, Holbrook M. Tick-borne flaviviruses. Clin Lab Med. 2010;30(1):221–235.

6. Rendi-Wagner P. Risk and prevention of tick-borne encephalitis in travelers. J Travel Med. 2004;11(5):307–312.

7. McNeil JG, Lednar WM, Stansfield SK, Prier RE, Miller RN. Central European tick-borne encephalitis: assessment of risk for persons in the armed services and vacationers. J Infect Dis. 1985;152(3):650–651.

8. Clement J, Leirs H, Armour V, et al. Serologic evidence for tick-borne encephalitis (TBE) in North-American military stationed in Germany. Acta Leiden. 1992;60(2):15–17.

9. Kunz C, Heinz FX, Hofmann H. Immunogenicity and reactogenicity of a highly purified vaccine against tick-borne encephalitis. J Med Virol. 1980;6(2):103–109.

10. Barrett PN, Dorner F, 1994. Tick-borne encephalitis vaccine. In: Plotkin SA, Mortimer EA, eds. Vaccines. 2nd ed. Philadelphia, PA: W. B. Saunders Company, 715–727.

11. Office of the Assistant Secretary of Defense. Health Affairs Policy Memorandum—Policy for Tick-Borne Encephalitis Preventive Measures for U.S. Forces Deployed During Operation Joint Endeavor. HA Policy 96-031. 20 February 1996.

12. Craig SC, Pittman PR, Lewis TE, et al. An accelerated schedule for tick-borne encephalitis vaccine: the American military experience in Bosnia. Am J Trop Med Hyg. 1999;61(6):874–878.

13. Kunze U, ISW-TBE. Tick-borne encephalitis—a notifiable disease: report of the 15th Annual Meeting of the International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE). Ticks Tick Borne Dis. 2013;4(5):363–365.

14. Sumilo D, Bormane A, Vasilenko V, et al. Upsurge of tick-borne encephalitis in the Baltic States at the time of political transition, independent of changes in public health practices. Clin Microbiol Infect. 2009;15(1):75–80.

15. Heinz FX, Stiasny K, Holzmann H, Grgic-Vitek M, Kriz B, Essl A, Kundi M. Vaccination and tick-borne encephalitis, central Europe. Emerg Infect Dis. 2013;19(1):69–76.

16. Kunz C. TBE vaccination and the Austrian experience. Vaccine. 2003;21(suppl 1):s50–s55.

17. Heinz FX, Stiasny K, Holzmann H, et al. Emergence of tick-borne encephalitis in new endemic areas in Austria: 42 years of surveillance. Euro Surveill. 2015;20(13):9–16.

18. World Health Organization. Vaccines against tick-borne encephalitis: WHO position paper. Wkly Epidemiol Rec. 2011;86(24):241–256.

19. European Centre for Disease Prevention and Control. Epidemiological situation of tick-borne encephalitis in the European Union and European Free Trade Association countries. https://ecdc.europa.eu/publications-data/epidemiological-situation-tick-borne-encephalitis-european-union-andeuropean. Accessed 17 October 2019.

20. Office of the Under Secretary of Defense for Personnel and Readiness. Department of Defense Instruction 6205.02. DoD Immunization Program. 23 July 2019.

21. Headquarters, U.S. Department of Defense. Directive 6200.04, Force Health Protection (FHP). 23 April 2007.

22. Office of the Under Secretary of Defense for Personnel and Readiness. Department of Defense Instruction 1010.10. Health Promotion and Disease Prevention. 12 January 2018.

23. Office of the Under Secretary of Defense for Personnel and Readiness. Department of Defense Instruction 6200.02. Application of Food and Drug Administration (FDA) Rules to Department of Defense Force Health Protection Programs. 27 February 2008.

24. Office of the Assistant Secretary of Defense Health Affairs. Chapter 12, Section 1.2. TRICARE Overseas Program (TOP) Medical Benefit Variations. In: TRICARE Policy Manual 6010.57-M. 1 February 2008.

25. Botelho-Nevers E, Gagneux-Brunon A, Velay A, et al. Tick-borne encephalitis in Auvergne-Rhône-Alpes region, France, 2017–2018. Emerg Infect Dis. 2019;25(10):1944–1948.

You also may be interested in...

Surveillance Snapshot: Illness and Injury Burdens, Recruit Trainees, Active Component, U.S. Armed Forces, 2018

Article
5/1/2019
U.S. Navy sailors graduate from boot camp at Recruit Training Command (RTC) in 2018. (Photo courtesy of U.S. Navy)

Recommended Content:

Medical Surveillance Monthly Report

Medical evacuations out of the U.S. Central Command, active and reserve components, U.S. Armed Forces, 2018

Article
5/1/2019
Airmen from the 19th Medical Group litter-carry a simulated patient onto a C-130J during an aeromedical evacuation training mission at Little Rock Air Force Base in 2019. (Photo Courtesy of U.S. Air Force)

The number of medical evacuations for battle injuries has decreased considerably since 2014. Most medical evacuations in 2018 were attributed to mental health disorders, followed by non-battle injury/poisoning; signs, symptoms, and ill-defined conditions; musculoskeletal disorders; and digestive system disorders.

Recommended Content:

Medical Surveillance Monthly Report

Absolute and relative morbidity burdens attributable to various illnesses and injuries, non-service member beneficiaries of the Military Health System, 2018

Article
5/1/2019
A senior airman of 366th Medical Support Squadron pediatric clinic checks vitals of the child of its service member at Mountain Home Air Force Base in Idaho. (Photo courtesy of U.S. Air Force)

In 2018, mental health disorders accounted for the largest proportions of the morbidity and healthcare burdens that affected the pediatric and younger adult beneficiary age groups. Among adults aged 45–64 years, musculoskeletal diseases accounted for the most morbidity and healthcare burdens, and among adults aged 65 years or older, cardiovascular diseases accounted for the most.

Recommended Content:

Medical Surveillance Monthly Report

Morbidity burdens attributable to various illnesses and injuries, deployed active and reserve component service members, U.S. Armed Forces, 2018

Article
5/1/2019
A U.S. naval officer listens through his stethoscope to hear his patient’s lungs at Camp Schwab in Okinawa, Japan in 2018. (Photo courtesy of U.S. Marine Corps) photo by Lance Cpl. Cameron Parks)

Among service members deployed during 2018, injury/poisoning, musculoskeletal diseases, and signs/symptoms accounted for more than half of the total healthcare burden while deployed. Compared to the distribution of major burden of disease categories documented in garrison, a relatively greater proportion of in-theater medical encounters due to respiratory infections, skin diseases, infectious/parasitic diseases, and digestive diseases was documented.

Recommended Content:

Medical Surveillance Monthly Report

Heat Illness

Infographic
4/1/2019
Heat Illness

This report summarizes reportable medical events of heat illness as well as heat illness-related hospitalizations and ambulatory visits among active component service members during 2018 and compares them to the previous 4 years. Episodes of heat stroke and heat exhaustion are summarized separately.

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Branch | Epidemiology and Analysis | Medical Surveillance Monthly Report | Public Health

Exertional Rhabdomyolysis

Infographic
4/1/2019
Exertional Rhabdomyolysis

Each year, the MSMR summarizes the numbers, rates, trends, risk factors, and locations of occurrences of exertional heat injuries, including exertional rhabdomyolysis. This report includes the data for 2014–2018.

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Branch | Epidemiology and Analysis | Medical Surveillance Monthly Report | Public Health

Exertional Hyponatremia

Infographic
4/1/2019
Exertional Hyponatremia

Each year, the MSMR summarizes the numbers, rates, trends, risk factors, and locations of occurrences of exertional heat injuries, including exertional rhabdomyolysis. This report includes the data for 2014–2018.

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Branch | Epidemiology and Analysis | Medical Surveillance Monthly Report | Public Health

Lyme Disease

Infographic
4/1/2019
Lyme Disease

Each year, the MSMR summarizes the numbers, rates, trends, risk factors, and locations of occurrences of exertional heat injuries, including exertional rhabdomyolysis. This report includes the data for 2014–2018.

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Branch | Epidemiology and Analysis | Medical Surveillance Monthly Report | Public Health

Update: Exertional Rhabdomyolysis, Active Component, U.S. Armed Forces, 2014–2018

Article
4/1/2019
U.S. Marines sprint uphill during a field training exercise at Marine Corps Air Station Miramar, California. to maintain contact with an aviation combat element, teaching and sustaining their proficiency in setting up and maintaining communication equipment.  (Photo Courtesy: U.S. Marine Corps)

Among active component service members in 2018, there were 545 incident diagnoses of rhabdomyolysis likely due to exertional rhabdomyolysis, for an unadjusted incidence rate of 42.0 cases per 100,000 person-years. Subgroup-specific rates in 2018 were highest among males, those less than 20 years old, Asian/Pacific Islander service members, Marine Corps and Army members, and those in combat-specific or “other/unknown” occupations. During 2014–2018, crude rates of exertional rhabdomyolysis increased steadily from 2014 through 2016 after which rates declined slightly in 2017 before increasing again in 2018. Compared to service members in other race/ethnicity groups, the overall rate of exertional rhabdomyolysis was highest among non-Hispanic blacks in every year except 2018. Overall and annual rates were highest among Marine Corps members, intermediate among those in the Army, and lowest among those in the Air Force and Navy. Most cases of exertional rhabdomyolysis were diagnosed at installations that support basic combat/recruit training or major ground combat units of the Army or the Marine Corps. Medical care providers should consider exertional rhabdomyolysis in the differential diagnosis when service members (particularly recruits) present with muscular pain or swelling, limited range of motion, or the excretion of dark urine (possibly due to myoglobinuria) after strenuous physical activity, particularly in hot, humid weather.

Recommended Content:

Medical Surveillance Monthly Report

Update: Heat Illness, Active Component, U.S. Armed Forces, 2018

Article
4/1/2019
Drink water the day before and during physical activity or if heat is going to become a factor. (Photo Courtesy: U.S. Air Force)

In 2018, there were 578 incident diagnoses of heat stroke and 2,214 incident diagnoses of heat exhaustion among active component service members. The overall crude incidence rates of heat stroke and heat exhaustion diagnoses were 0.45 cases and 1.71 cases per 1,000 person-years, respectively. In 2018, subgroup-specific rates of incident heat stroke diagnoses were highest among males and service members less than 20 years old, Asian/Pacific Islanders, Marine Corps and Army members, recruit trainees, and those in combat-specific occupations. Subgroup-specific incidence rates of heat exhaustion diagnoses in 2018 were notably higher among service members less than 20 years old, Asian/Pacific Islanders, Army and Marine Corps members, recruit trainees, and service members in combat-specific occupations. During 2014–2018, a total of 325 heat illnesses were documented among service members in Iraq and Afghanistan; 8.6% (n=28) were diagnosed as heat stroke. Commanders, small unit leaders, training cadre, and supporting medical personnel must ensure that the military members whom they supervise and support are informed about the risks, preventive countermeasures, early signs and symptoms, and first-responder actions related to heat illnesses.

Recommended Content:

Medical Surveillance Monthly Report

Modeling Lyme Disease Host Animal Habitat Suitability, West Point, New York

Article
4/1/2019
A deer basks in the morning sun at Joint Base San Antonio-Fort Sam Houston, Texas.  (Photo Courtesy: U.S. Air Force)

As the most frequently reported vector-borne disease among active component U.S. service members, with an incidence rate of 16 cases per 100,000 person-years in 2011, Lyme disease poses both a challenge to healthcare providers in the Military Health System and a threat to military readiness. Spread through the bite of an infected blacklegged tick, infection with the bacterial cause of Lyme disease can have lasting effects that may lead to medical discharge from the military. The U.S. Military Academy at West Point is situated in a highly endemic area in New York State. To identify probable areas where West Point cadets as well as active duty service members stationed at West Point and their families might contract Lyme disease, this study used Geographic Information System mapping methods and remote sensing data to replicate an established spatial model to identify the likely habitat of a key host animal—the white-tailed deer.

Recommended Content:

Medical Surveillance Monthly Report

Incidence, Timing, and Seasonal Patterns of Heat Illnesses During U.S. Army Basic Combat Training, 2014–2018

Article
4/1/2019
U.S. Marines participate in morning physical training during a field exercise at Marine Corps Base Camp Pendleton, California. (Photo Courtesy: U.S. Marine Corps)

Risk factors for heat illnesses (HIs) among new soldiers include exercise intensity, environmental conditions at the time of exercise, a high body mass index, and conducting initial entry training during hot and humid weather when recruits are not yet acclimated to physical exertion in heat. This study used data from the Defense Health Agency’s–Weather-Related Injury Repository to calculate rates and to describe the incidence, timing, and geographic distribution of HIs among soldiers during U.S. Army basic combat training (BCT). From 2014 through 2018, HI events occurred in 1,210 trainees during BCT, resulting in an overall rate of 3.6 per 10,000 BCT person-weeks (p-wks) (95% CI: 3.4–3.8). HI rates (cases per 10,000 BCT p-wks) varied among the 4 Army BCT sites: Fort Benning, GA (6.8); Fort Jackson, SC (4.4); Fort Sill, OK (1.8); and Fort Leonard Wood, MO (1.7). Although the highest rates ofHIs occurred at Fort Benning, recruits in all geographic areas were at risk. The highest rates of HI occurred during the peak training months of June through September, and over half of all HI cases affected soldiers during the first 3 weeks of BCT. Prevention of HI among BCT soldiers requires relevant training of both recruits and cadre as well as the implementation of effective preventive measures.

Recommended Content:

Medical Surveillance Monthly Report

Update: Exertional Hyponatremia, Active Component, U.S. Armed Forces, 2003–2018

Article
4/1/2019
Drink water the day before and during physical activity or if heat is going to become a factor. (Photo Courtesy: U.S. Air Force)

From 2003 through 2018, there were 1,579 incident diagnoses of exertional hyponatremia among active component service members, for a crude overall incidence rate of 7.2 cases per 100,000 person-years (p-yrs). Compared to their respective counterparts, females, those less than 20 years old, and recruit trainees had higher overall incidence rates of exertional hyponatremia diagnoses. The overall incidence rate during the 16-year period was highest in the Marine Corps, intermediate in the Army and Air Force, and lowest in the Navy. Overall rates during the surveillance period were highest among Asian/Pacific Islander and non-Hispanic white service members and lowest among non-Hispanic black service members. Between 2003 and 2018, crude annual incidence rates of exertional hyponatremia peaked in 2010 (12.7 per 100,000 p-yrs) and then decreased to 5.3 cases per 100,000 p-yrs in 2013 before increasing in 2014 and 2015. The crude annual rate in 2018 (6.3 per 100,000 p-yrs) represented a decrease of 26.5% from 2015. Service members and their supervisors must be knowledgeable of the dangers of excessive water consumption and the prescribed limits for water intake during prolonged physical activity (e.g., field training exercises, personal fitness training, and recreational activities) in hot, humid weather.

Recommended Content:

Medical Surveillance Monthly Report

Testosterone Replacement Therapy

Infographic
3/20/2019
Testosterone Replacement Therapy

With the increasing number of testosterone deficiency diagnoses and potential health risks associated with initiation of TRT, it is important to understand the epidemiology of which U.S. service men are receiving TRT and whether these individuals have an indication for receiving treatment.

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Branch | Epidemiology and Analysis | Medical Surveillance Monthly Report | Public Health

Sexually Transmitted Infections

Infographic
3/20/2019
Sexually Transmitted Infections

This report summarizes incidence rates of the 5 most common sexually transmitted infections (STIs) among active component service members of the U.S. Armed Forces during 2010–2018.

Recommended Content:

Health Readiness | Armed Forces Health Surveillance Branch | Epidemiology and Analysis | Medical Surveillance Monthly Report | Public Health
<< < ... 6 7 8 9 10  ... > >> 
Showing results 76 - 90 Page 6 of 11

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.